1. Much Ado About Nipples

   • Suzanne B. Coopey

   Breast Oncology 18 October 2019 Pages: 321 - 322

2. Extended Radical Resection: The Standard of Care for Patients with Advanced Pelvic Malignancy

   • Michael J. Solomon
   • Kilian G. M. Brown

   Colorectal Cancer 13 September 2019 Pages: 323 - 324

3. Invited Editorial: “The Head and Neck Reconstructive Surgery National Surgical Quality Improvement Program (NSQIP): Evaluating Unplanned Returns to the Operating Room” by Tam S et al.

   • Matthew M. Hanasono

   Reconstructive Oncology 17 September 2019 Pages: 325 - 326

4. Editorial on “Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy”

   • J. Y. K. Chan
   • F. C. Holsinger

   Head and Neck Oncology 23 September 2019 Pages: 327 - 328

5. Clinical T4b Esophageal Cancer: Can We Make an “Unresectable” Tumour Resectable?

   • Lorenzo Ferri

   Thoracic Oncology 22 August 2019 Pages: 329 - 330

6. Are Lobe-Specific Mediastinal Lymph Node Dissections Reasonable for Peripheral Stage Ia Non-small Cell Lung Cancer?

   • Justin M. Karush

   Thoracic Oncology 06 November 2019 Pages: 331 - 332

7. Size and Importance of Socioeconomic Status-Based Disparities in Use of Surgery in Nonadvanced Stage Gastrointestinal Cancers

   • Douglas S. Swords
   • Sean J. Mulvihill
   • Courtney L. Scaife

   Health Services Research and Global Oncology 11 October 2019 Pages: 333 - 341

   

8. ASO Author Reflections: Socioeconomic Disparities in Use of Surgery for Gastrointestinal Cancers Are Large and Impactful in Poor-Prognosis Cancers

   • Douglas S. Swords
   • Courtney L. Scaife

   ASO Author Reflections 04 November 2019 Pages: 342 - 343

9. Increase in Utilization of Nipple-Sparing Mastectomy for Breast Cancer: Indications, Complications, and Oncologic Outcomes

   • Monica G. Valero
   • Shirin Muhsen
   • Virgilio S. Sacchini

   Breast Oncology 10 December 2019 Pages: 344 - 351

   

10. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer

    • Olga Kantor
    • Jean Bao
    • Jennifer Tseng

    Breast Oncology 02 August 2019 Pages: 352 - 358

    

11. Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors

    • Min Yi
    • Heather Lin
    • Elizabeth A. Mittendorf

    Breast Oncology 30 October 2019 Pages: 359 - 366

    

12. Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers

    • Ko Un Park
    • Anna Weiss
    • Alastair Thompson

    Breast Oncology 09 August 2019 Pages: 367 - 372

    

13. ASO Author Reflections: Key Challenges in Expanding the Utilization of Nipple-Sparing Mastectomy

    • Ko Un Park

    ASO Author Reflections 28 October 2019 Pages: 373 - 374

14. Internal Mammary Sentinel Lymph Node Biopsy in Clinically Axillary Lymph Node-Positive Breast Cancer: Diagnosis and Implications for Patient Management

    • Peng-Fei Qiu
    • Rong-Rong Zhao
    • Yong-Sheng Wang

    Breast Oncology Open access 12 August 2019 Pages: 375 - 383

    

15. ASO Author Reflections: Internal Mammary Sentinel Lymph Node Biopsy—Time for the Back of Internal Mammary Staging?

    • Peng-Fei Qiu
    • Yong-Sheng Wang

    ASO Author Reflections Open access 06 November 2019 Pages: 384 - 385

16. Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer

    • William H. Ward
    • Lyudmila DeMora
    • Richard J. Bleicher

    Breast Oncology Open access 27 September 2019 Pages: 386 - 396

    

17. ASO Author Reflections: Delays in the Treatment of DCIS—What are the Costs?

    • William H. Ward
    • Richard J. Bleicher

    ASO Author Reflections 11 November 2019 Pages: 397 - 398

18. Assessment of DIEP Flap Perfusion with Intraoperative Indocyanine Green Fluorescence Imaging in Vasopressor-Dominated Hemodynamic Support Versus Liberal Fluid Administration: A Randomized Controlled Trial With Breast Cancer Patients

    • Alexandra M. Anker
    • Lukas Prantl
    • Silvan M. Klein

    Reconstructive Oncology 29 August 2019 Pages: 399 - 406

    

19. ASO Author Reflections: The Silent Force Behind Microsurgery

    • Alexandra M. Anker
    • Lukas Prantl
    • Silvan M. Klein

    ASO Author Reflections 30 October 2019 Pages: 407 - 408

20. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience

    • Oliver Peacock
    • Peadar S. Waters
    • Jacob J. McCormick

    Colorectal Cancer 13 September 2019 Pages: 409 - 414

21. ASO Author Reflections: Major Morbidity After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies

    • Oliver Peacock
    • Peadar S. Waters
    • Jacob J. McCormick

    ASO Author Reflections 04 November 2019 Pages: 415 - 416

22. MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial

    • Martin E. Kreis
    • Reinhard Ruppert
    • For the OCUM group

    Colorectal Cancer 14 August 2019 Pages: 417 - 427

    

23. ASO Author Reflections: From Overtreatment to Risk-Adjusted Therapy of Rectal Carcinoma

    • Theodor Junginger

    ASO Author Reflections 28 October 2019 Pages: 428 - 429

24. Prognostic Impact of Ventral Versus Dorsal Tumor Location After Total Mesorectal Excision of Rectal Cancer

    • Clemens Franz
    • Hans M. Lang
    • Yakup Kulu

    Colorectal Cancer 23 September 2019 Pages: 430 - 438

    

25. ASO Author Reflections: Tumor Location Affects Local Recurrence in Rectal Cancer

    • Clemens Franz
    • Yakup Kulu

    ASO Author Reflections 31 October 2019 Pages: 439 - 439

26. Evaluating Unplanned Returns to the Operating Room in Head and Neck Free Flap Patients

    • Samantha Tam
    • Randal S. Weber
    • Carol M. Lewis

    Head and Neck Oncology 13 August 2019 Pages: 440 - 448

27. ASO Author Reflections: Unplanned Return to the Operating Room: Implementing a Specialty-Specific NSQIP in Patients Undergoing Head and Neck Surgery with Free Flap Reconstruction

    • Samantha Tam
    • Randal S. Weber
    • Carol M. Lewis

    ASO Author Reflections 29 October 2019 Pages: 449 - 450

28. Predictors and Prevalence of Nodal Disease in Salvage Oropharyngectomy

    • M. E. Heft Neal
    • J. Brennan
    • M. E. Spector

    Head and Neck Oncology 19 September 2019 Pages: 451 - 457

    

29. ASO Author Reflections: Nodal Disease in Recurrent Oropharynx

    • Molly E. Heft Neal
    • Matthew E. Spector

    ASO Author Reflections 28 October 2019 Pages: 458 - 459

30. A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer

    • Tomoya Yokota
    • Ken Kato
    • Yuko Kitagawa

    Thoracic Oncology 02 August 2019 Pages: 460 - 467

    

31. ASO Author Reflections: How Should the Patients with Locally Advanced Unresectable Esophageal Cancer Be Treated with Multidisciplinary Approach?

    • Tomoya Yokota
    • Yuko Kitagawa

    ASO Author Reflections 04 November 2019 Pages: 468 - 469

32. ASO Author Reflections: Lobe-Specific Lymph Node Dissection for Early-Stage Non-small Cell Lung Cancer: A Long Way to Go in the Era of Minimally Invasive Thoracic Surgery

    • Han-Yu Deng
    • Qinghua Zhou

    ASO Author Reflections 16 October 2019 Pages: 470 - 471

33. Lobe-Specific Lymph Node Dissection for Clinical Early-Stage (cIA) Peripheral Non-small Cell Lung Cancer Patients: What and How?

    • Han-Yu Deng
    • Jie Zhou
    • Qinghua Zhou

    Thoracic Oncology 15 October 2019 Pages: 472 - 480

    

34. The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer

    • Shuichi Shinohara
    • Ryo Otsuki
    • Makoto Nakagawa

    Thoracic Oncology 12 August 2019 Pages: 481 - 489

    

35. ASO Author Reflections: The Possibility of a New Prognostic Biomarker of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer

    • Shuichi Shinohara
    • Kenichi Kobayashi
    • Makoto Nakagawa

    ASO Author Reflections 28 October 2019 Pages: 490 - 491

36. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer

    • Yuichiro Nakashima
    • Hiroshi Saeki
    • Masaki Mori

    Thoracic Oncology 23 September 2019 Pages: 492 - 498

    

37. ASO Author Reflections: Significance of Skeletal Muscle Loss After Esophagectomy for Esophageal Cancer

    • Yuichiro Nakashima
    • Masaki Mori

    ASO Author Reflections 21 November 2019 Pages: 499 - 499

38. Higher Doses of Neoadjuvant Radiation for Esophageal Cancer Do Not Affect the Pathologic Complete Response Rate or Survival: A Propensity-Matched Analysis

    • Stephanie G. Worrell
    • Christopher W. Towe
    • Philip A. Linden

    Thoracic Oncology 30 September 2019 Pages: 500 - 508

    

39. ASO Author Reflections: More May Not Be Better

    • Stephanie G. Worrell
    • Philip A. Linden

    ASO Author Reflections 31 October 2019 Pages: 509 - 510

40. For Gastroesophageal Junction Cancers, Does an “Esophageal” or “Gastric” Surgical Approach Offer Better Perioperative and Oncologic Outcomes?

    • Jennifer Tseng
    • Mitchell C. Posner

    Gastrointestinal Oncology 30 September 2019 Pages: 511 - 517

    

41. Short-Term Outcomes of Laparoscopic and Open Total Gastrectomy for Gastric Cancer: A Nationwide Retrospective Cohort Analysis

    • Takashi Sakamoto
    • Michimasa Fujiogi
    • Hideo Yasunaga

    Gastrointestinal Oncology 12 August 2019 Pages: 518 - 526

42. ASO Author Reflections: Anastomotic Complications are More Prevalent in Laparoscopic Total Gastrectomy than in Open Total Gastrectomy

    • Takashi Sakamoto
    • Michimasa Fujiogi
    • Hideo Yasunaga

    ASO Author Reflections 30 October 2019 Pages: 527 - 528

43. Laparoscopic Suprapancreatic Lymph Node Dissection Using a Systematic Mesogastric Excision Concept for Gastric Cancer

    • Tsutomu Kumamoto
    • Yasunori Kurahashi
    • Hisashi Shinohara

    Gastrointestinal Oncology 12 August 2019 Pages: 529 - 531

    

44. ASO Author Reflections: Systematic Mesogastric Excision as a Universal Concept in Gastric Cancer Surgery

    • Tsutomu Kumamoto
    • Hisashi Shinohara

    ASO Author Reflections 25 October 2019 Pages: 532 - 533

45. Prognostic Value of Lymph Node Yield After Neoadjuvant Chemoradiation for Gastric Cancer

    • Casey J. Allen
    • Timothy J. Vreeland
    • Brian D. Badgwell

    Gastrointestinal Oncology 24 September 2019 Pages: 534 - 542

    

46. ASO Author Reflections: Do Advances in Neoadjuvant Therapy Influence How We Surgically Manage the Regional Lymphatics in Gastric Cancer?

    • Casey J. Allen
    • Brian D. Badgwell

    ASO Author Reflections 24 October 2019 Pages: 543 - 544

47. Prognostic Performance of Preoperative Staging: Assessed by Using Multidetector Computed Tomography—Between the New Clinical Classification and the Pathological Classification in the Eighth American Joint Committee on Cancer Classification for Gastric Carcinoma

    • Oh Jeong
    • Mi Ran Jung
    • Seong Yeob Ryu

    Gastrointestinal Oncology 23 October 2019 Pages: 545 - 551

    

48. Advances in the Diagnosis and Treatment of Patients with Intrahepatic Cholangiocarcinoma

    • Aslam Ejaz
    • Jordan M. Cloyd
    • Timothy M. Pawlik

    Hepatobiliary Tumors 25 September 2019 Pages: 552 - 560

    

49. Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis

    • Amanda A. G. Nijhuis
    • Ivan D. de A. O. Santos Filho
    • Omgo E. Nieweg

    Melanoma 12 August 2019 Pages: 561 - 568

    

50. ASO Author Reflections: Melanoma Patients with a Local Recurrence or In-Transit Metastasis: Sentinel Node Biopsy to Identify Those at Highest Risk of Metastases and Death

    • Amanda A. G. Nijhuis
    • Omgo E. Nieweg

    ASO Author Reflections 30 October 2019 Pages: 569 - 570